← Back to all trials
Completed
NCT02181179
Examining Yoga's Effects on Smoking
Conditions: Yoga, Waitlist
Sex: Female
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 50
Sponsor: Jasper A. Smits
Location: University of Texas at Austin Austin Texas
Summary
The primary aim of this research study is to examine the effects of an 8-week yoga program on aspects related to nicotine dependence, stress, and coping during a smoking quit attempt.
Guided by initial studies reporting on the effects of yoga on putative mediators of smoking relapse (i.e., cortisol, distress intolerance, withdrawal symptoms), the proposed experiment examines the effects of an 8-week yoga practice on nicotine withdrawal intensity by way of aiding withdrawal characteristics predictive of smoking relapse. The long-term objectives of the proposed line of research are to: (1) inform theoretical models of nicotine withdrawal, (2) guide the development of effective alternative interventions for smokers susceptible to relapse during the critical withdrawal period (i.e., smokers low in distress tolerance), and (3) to help guide behavioral strategies for treating substance addictions broadly.
Eligibility Criteria
Inclusion Criteria:
* Female only patients ages 18-65 capable of providing informed consent
* Daily smoker for at least one year.
* Currently smoke an average of at least 10 cigarettes per day.
* Sedentary as defined by moderate-intensity exercise less than 2 days/wk for at least 30 minutes each
* Written physician approval/medical clearance to participate in an exercise/yoga protocol.
-Report motivation to quit smoking of at least 5 on a 10-point Likert-type scale - -Express interest in making a serious, unassisted quit attempt in the next month-
* Have not decreased number of cigarettes smoked in the past 6 months
Exclusion Criteria:
* Use of other tobacco products
* Severe obesity (BMI ≥ 40)
* Currently pregnant or plans to become pregnant
* Diagnosis of a schizophrenia or bipolar-spectrum disorder
* Currently suicidal or suicide high-risk or severe depression
* Use of corticosteroid medications
* Change in medication doses for past 6-months for psychotropic drugs
* Receiving concurrent psychotherapy
Source: ClinicalTrials.gov (NCT02181179). StuddyBuddy aggregates publicly available trial information.